1.中山大学附属第三医院肿瘤内科,广东 广州 510630
2.中山大学附属第三医院妇产科,广东 广州 510630
杨春雨,第一作者,研究方向:肝细胞癌,E-mail:yangchy65@mail2.sysu.edu.cn
收稿:2026-03-23,
修回:2026-04-18,
录用:2026-04-29,
纸质出版:2026-05-20
移动端阅览
杨春雨,乔亦丹,孙张玥等.CD8+ T细胞与活化的肝星状细胞在门静脉癌栓中的关键配体-受体轴驱动基质激活和T细胞重编程[J].中山大学学报(医学科学版),2026,47(03):482-495. DOI: 10.11714/jsysu.med.YX20260048.
YANG Chunyu,QIAO Yidan,SUN Zhangyue,et al.Key Ligand-receptor Axes Between CD8+ T Cells and Activated Hepatic Stellate Cells in Portal Vein Tumor Thrombus Drive Stromal Activation and T-cell Reprogramming[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(03):482-495. DOI: 10.11714/jsysu.med.YX20260048.
杨春雨,乔亦丹,孙张玥等.CD8+ T细胞与活化的肝星状细胞在门静脉癌栓中的关键配体-受体轴驱动基质激活和T细胞重编程[J].中山大学学报(医学科学版),2026,47(03):482-495. DOI: 10.11714/jsysu.med.YX20260048. DOI:
YANG Chunyu,QIAO Yidan,SUN Zhangyue,et al.Key Ligand-receptor Axes Between CD8+ T Cells and Activated Hepatic Stellate Cells in Portal Vein Tumor Thrombus Drive Stromal Activation and T-cell Reprogramming[J].Journal of Sun Yat-sen University(Medical Sciences),2026,47(03):482-495. DOI: 10.11714/jsysu.med.YX20260048. DOI:
目的
2
鉴定可能有助于优化伴门静脉癌栓(PVTT)肝细胞癌免疫治疗策略的关键配体-受体作用轴。
方法
2
从基因表达综合数据库(GEO)下载正常组织(Norm)和PVTT组织的单细胞转录组测序数据,并进行整合分析与细胞注释。采用CellChat推断细胞间通讯网络并比较信号通路活性,从而筛选差异显著的候选配体-受体作用轴。随后,利用多重免疫荧光(mIF)在组织水平评估候选作用轴相关信号的空间分布特征。在细胞水平上,进一步通过qPCR和流式细胞术检测外周血来源CD8
+
T细胞及人肝星状细胞系LX-2中关键配体和受体的表达情况。最后,结合重组蛋白刺激以及拮抗剂或中和阻断实验,对其功能效应进行体外验证。
结果
2
分析结果显示,在PVTT中,CD8
+
T细胞与活化肝星状细胞(aHSCs)之间存在显著的双向通讯。由CD8
+
T细胞指向aHSCs的通讯中,SPP1-CD44轴最为突出;而在相反方向上,MIF-(CD74+CD44)轴获得了较强支持。上述两条作用轴均在生物信息学筛选、组织空间定位分析以及细胞与功能实验验证中得到一致支持。
结论
2
SPP1-CD44轴和MIF-(CD74+CD44)轴可能通过促进间质活化及诱导T细胞功能重塑,共同参与塑造PVTT的免疫抑制性肿瘤微环境(ITME),并有望成为提高PVTT患者免疫治疗应答的潜在干预靶点。
Objective
2
To identify key ligand-receptor axes that may improve immunotherapeutic strategies for hepatocellular carcinoma with portal vein tumor thrombus (PVTT).
Methods
2
Single-cell RNA sequencing (scRNA-seq) data from normal tissues (Norm) and PVTT cells were downloaded from the gene expression omnibus (GEO) database, integrated, and annotated. CellChat was used to infer intercellular communication and compare pathway activities to screen
significantly differential candidate ligand-receptor axes. Multiplex immunofluorescence (mIF) was then performed to evaluate the spatial distribution of signals related to candidate axes at the tissue level. The expression of key ligands and receptors was validated by qPCR and flow cytometry in peripheral blood-derived CD8
+
T cells and the human hepatic stellate cell line LX-2. Functional effects were further assessed in vitro using recombinant proteins and antagonists or neutralizing blockers.
Results
2
The analysis revealed strong bidirectional communication between CD8
+
T cells and activated hepatic stellate cells (aHSCs) in PVTT. The SPP1-CD44 axis was the most prominent in the direction from CD8
+
T cells to aHSCs, whereas the MIF-(CD74+ CD44) axis was strongly supported in the opposite direction. These axes were consistently supported by bioinformatic screening, tissue spatial analysis, and cellular or functional validation.
Conclusion
2
The SPP1-CD44 and the MIF-(CD74+ CD44) axes may collectively shape the immunosuppressive tumor microenvironment (ITME) of PVTT through stromal activation and T-cell functional reprogramming, suggesting potential targets for improving immunotherapeutic responsiveness in patients with PVTT.
Sung H , Ferlay J , Siegel RL , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
Villanueva A . Hepatocellular carcinoma [J]. N Engl J Med , 2019 , 380 ( 15 ): 1450 - 1462 .
Yeung YP , Lo CM , Liu CL , et al . Natural history of untreated nonsurgical hepatocellular carcinoma [J]. AM J Gastroenterol , 2005 , 100 ( 9 ): 1995 - 2004 .
Zhang ZM , Lai EC , Zhang C , et al . The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus [J]. Int J Surg , 2015 , 20 : 8 - 16 .
Cheng S , Chen M , Cai J , et al . Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 Edition) [J]. Liver Cancer , 2020 , 9 ( 1 ): 28 - 40 .
沈未 , 鲁迪 , 徐骁 . 肝癌肝移植适应证的科学演进 [J]. 器官移植 , 2025 , 16 ( 2 ): 202 - 207 .
Shen W , Lu D , Xu X . Scientific evolution of indications for liver transplantation in hepatocellular carcinoma [J]. Organ Transpl , 2025 , 16 ( 2 ): 202 - 207 .
Forner A , Llovet JM , Bruix J . Hepatocellular carcinoma [J]. Lancet , 2012 , 379 ( 9822 ): 1245 - 1255 .
Pawarode A , Voravud N , Sriuranpong V , et al . Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients [J]. Am J Clin Oncol , 1998 , 21 ( 4 ): 386 - 391 .
Heimbach JK , Kulik LM , Finn RS , et al . AASLD guidelines for the treatment of hepatocellular carcinoma [J]. Hepatology , 2018 , 67 ( 1 ): 358 - 80 .
Nakazawa T , Hidaka H , Shibuya A , et al . Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis [J]. BMC Gastroenterol , 2014 , 14 : 84 .
Cheng AL , Qin S , Ikeda M , et al . Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma [J]. J Hepatol , 2022 , 76 ( 4 ): 862 - 873 .
Ren Z , Xu J , Bai Y , et al . Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study [J]. Lancet Oncol , 2021 , 22 ( 7 ): 977 - 990 .
Qin S , Chan SL , Gu S , et al . Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study [J]. Lancet , 2023 , 402 ( 10408 ): 1133 - 1146 .
Lin T , Lin Z , Mai P , et al . Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma [J]. Aging , 2021 , 13 ( 8 ): 11786 - 11807 .
Liu X , Liu Z , Zhu C , et al . Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma [J]. Nat Commun. , 2025 , 16 ( 1 ): 10416 .
Stuart T , Butler A , Hoffman P , et al . Comprehensive integration of single-cell data [J]. Cell , 2019 , 177 ( 7 ): 1888 - 1902 .
Zhou XH , Li JR , Zheng TH , et al . Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy [J]. Clin Exp Metastas , 2023 , 40 ( 1 ): 5 - 32 .
Wang PW , Lin TY , Yang PM , et al . Hepatic stellate cell modulates the immune microenvironment in the progression of hepatocellular carcinoma [J]. Int J Mol Sci , 2022 , 23 ( 18 ): 10777 .
Cai N , Cheng K , Ma Y , et al . Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8(+ ) T cell-mediated antitumour immunity and improves anti-PD-1 efficacy [J]. Gut , 2024 , 73 ( 6 ): 985 - 999 .
Hao Y , Hao S , Andersen-Nissen E , et al . Integrated analysis of multimodal single-cell data [J]. Cell , 2021 , 184 ( 13 ): 3573 - 3587 .
Germain PL , Lun A , Garcia Meixide C , et al . Doublet identification in single-cell sequencing data using scDblFinder [J]. F1000Res , 2021 , 10 : 979 .
Ma G , Liu X , Jiang Q , et al . Identification of a stromal immunosuppressive barrier orchestrated by SPP1(+ )/C1QC(+ ) macrophages and CD8(+ ) exhausted T cells driving gastric cancer immunotherapy resistance [J]. Front Immunol , 2025 , 16 : 1618591 .
Weiskirchen R , Weimer J , Meurer SK , et al . Genetic characteristics of the human hepatic stellate cell line LX-2 [J]. PloS one , 2013 , 8 ( 10 ): e75692 .
Jubel JM , Barbati ZR , Burger C , et al . The role of PD-1 in acute and chronic infection [J]. Front Immunol , 2020 , 11 : 487 .
Strijker JGM , Pascual-Pasto G , Grothusen GP , et al . Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma [J]. Eur J Cancer , 2025 , 218 : 115263 .
Ge T , Yang Y , Zhang W , et al . Tumor-intrinsic redox programming drives an SPP1-CD44 axis of immune suppression in uveal melanoma [J]. Redox Biol , 2026 , 90 : 104011 .
Zhao F , Niu X , Song G , et al . Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation [J]. Transl Med , 2025 , 23 ( 1 ): 810 .
Park I , Shin SJ , Go H , et al . Spatial analysis of tumor immune microenvironment of TNBC with different neoadjuvant chemotherapy outcomes using multiplex Immunofluorescence [J]. Breast Cancer RES : BCR , 2025 , 27 ( 1 ): 181 .
Xu L , Hui AY , Albanis E , et al . Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis [J]. Gut , 2005 , 54 ( 1 ): 142 - 151 .
Carlini V , Noonan DM , Abdalalem E , et al . The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions [J]. Front Immunol , 2023 , 14 : 1161067 .
Fang S , Yuan J , Shi Q , et al . Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway [J]. PloS one , 2017 , 12 ( 3 ): e0174374 .
Gao Z , Feng Y , Xu J , et al . T-cell exhaustion in immune-mediated inflammatory diseases: new implications for immunotherapy [J]. Front Immunol , 2022 , 13 : 977394 .
Pelizzaro F , Farinati F , Trevisani F . Immune checkpoint inhibitors in hepatocellular carcinoma: current strategies and biomarkers predicting response and/or resistance [J]. Biomedicines , 2023 , 11 ( 4 ): 1020 .
Akkız H , Gieseler RK , Canbay A . Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells [J]. Int J Mol Sci , 2024 , 25 ( 14 ): 7873 .
Shi Y , Wu W , Wan T , et al . Impact of polyclonal anti-CD3/CD28-coated magnetic bead expansion methods on T cell proliferation, differentiation and function [J]. Int Immunopharmacol , 2013 , 15 ( 1 ): 129 - 137 .
Casalegno Garduño R , Spitschak A , Pannek T , et al . CD8 + T cell subsets as biomarkers for predicting checkpoint therapy outcomes in cancer immunotherapy [J]. Biomedicines , 2025 , 13 ( 4 ): 930 .
Shigehara K , Kawai N , Shirosaki T , et al . The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma [J]. Sci Rep , 2025 , 15 ( 1 ): 26638 .
Zhao J , Lu Y , Wang Z , et al . Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence [J]. TLCR , 2024 , 13 ( 9 ): 2395 - 2410 .
Wang J , Liu C , Wang T , et al . Single-cell communication patterns and their intracellular information flow in synovial fibroblastic osteoarthritis and rheumatoid arthritis [J]. Immunol Lett , 2023 , 263 : 1 - 13 .
Jin S , Guerrero-Juarez CF , Zhang L , et al . Inference and analysis of cell-cell communication using CellChat [J]. Nat Commun , 2021 , 12 ( 1 ): 1088 .
Tong W , Wang T , Bai Y , et al . Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment [J]. Transl Med , 2024 , 22 ( 1 ): 840 .
Ionescu F , Nguyen J , Segura CM , et al . Multiplex immunofluorescence captures progressive immune exhaustion with advancing penile squamous cell cancer stage [J]. Cancers , 2024 , 16 ( 2 ): 303 .
Zhao J , Lu Y , Wang Z , et al . Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence [J]. TLCR , 2024 , 13 ( 9 ): 2395 - 2410 .
Yang J , Tang X , Liang Z , et al . Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions [J]. Clin Mol Hepatol , 2023 , 29 ( 2 ): 465 - 481 .
Zhao F , Niu X , Song G , et al . Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation [J]. Transl Med , 2025 , 23 ( 1 ): 810 .
Jeon EY , Baek SE , Kim JO , et al . A pivotal role for AP-1-mediated osteopontin expression in the increased migration of vascular smooth muscle cells stimulated with HMGB1 [J]. Front Physiol , 2021 , 12 : 775464 .
0
浏览量
13
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
